• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NPORT-P filed by abrdn Healthcare Investors Shares of Beneficial Interest

    11/15/23 3:13:25 PM ET
    $HQH
    Finance Companies
    Finance
    Get the next $HQH alert in real time by email
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549

    FORM NPORT-P
    Monthly Portfolio Investments Report

    NPORT-P: Filer Information

    Filer CIK
    0000805267 
    Filer CCC
    ********  
    Filer Investment Company Type
     
    Is this a LIVE or TEST Filing? live is not checked LIVE test is not checked TEST
    Would you like a Return Copy? return copy flag is not checked
    Is this an electronic copy of an official filing submitted in paper format? Confirm flag is not checked

    Submission Contact Information

    Name
     
    Phone
     
    E-Mail Address
     

    Notification Information

    Notify via Filing Website only?Override internet flag is not checked
    Series ID
     

    NPORT-P: Part A: General Information

    Item A.1. Information about the Registrant.

    a. Name of Registrant
    TEKLA HEALTHCARE INVESTORS 
    b. Investment Company Act file number for Registrant: (e.g., 811-______)
    811-04889 
    c. CIK number of Registrant
    0000805267 
    d. LEI of Registrant
    549300SNASESIFOS6V75 

    e. Address and telephone number of Registrant.
    Street Address 1
    100 FEDERAL STREET, 
    Street Address 2
    19TH FLOOR 
    City
    BOSTON 
    State, if applicable
    MASSACHUSETTS  
    Foreign country, if applicable
    UNITED STATES OF AMERICA  
    Zip / Postal Code
    02110 
    Telephone number
    617-772-8500 

    Item A.2. Information about the Series.

    a. Name of Series.
    TEKLA HEALTHCARE INVESTORS 
    b. EDGAR series identifier (if any).
     
    c. LEI of Series.
    549300SNASESIFOS6V75 

    Item A.3. Reporting period.

    a. Date of fiscal year-end.
    2023-09-30 
    b. Date as of which information is reported.
    2023-09-30 

    Item A.4. Final filing

    Does the Fund anticipate that this will be its final filing on Form N PORT?Yes is not checked Yes No is checked No

    NPORT-P: Part B: Information About the Fund

    Report the following information for the Fund and its consolidated subsidiaries.

    Item B.1. Assets and liabilities. Report amounts in U.S. dollars.

    a. Total assets, including assets attributable to miscellaneous securities reported in Part D.
    932481053.04 
    b. Total liabilities.
    1148703.39 
    c. Net assets.
    931332349.65 

    Item B.2. Certain assets and liabilities. Report amounts in U.S. dollars.

    a. Assets attributable to miscellaneous securities reported in Part D.
    0.00000000 
    b. Assets invested in a Controlled Foreign Corporation for the purpose of investing in certain types of instruments such as, but not limited to, commodities.
    0.00000000 

    c. Borrowings attributable to amounts payable for notes payable, bonds, and similar debt, as reported pursuant to rule 6-04(13)(a) of Regulation S-X [17 CFR 210.6-04(13)(a)].

    Amounts payable within one year.
    Banks or other financial institutions for borrowings.
    0.00000000 
    Controlled companies.
    0.00000000 
    Other affiliates.
    0.00000000 
    Others.
    0.00000000 
    Amounts payable after one year.
    Banks or other financial institutions for borrowings.
    0.00000000 
    Controlled companies.
    0.00000000 
    Other affiliates.
    0.00000000 
    Others.
    0.00000000 

    d. Payables for investments purchased either (i) on a delayed delivery, when-issued, or other firm commitment basis, or (ii) on a standby commitment basis.

    (i) On a delayed delivery, when-issued, or other firm commitment basis:
    0.00000000 
    (ii) On a standby commitment basis:
    0.00000000 
    e. Liquidation preference of outstanding preferred stock issued by the Fund.
    0.00000000 
    f. Cash and cash equivalents not reported in Parts C and D.
    213.54000000 

    Item B.3. Portfolio level risk metrics.

    If the average value of the Fund's debt securities positions for the previous three months, in the aggregate, exceeds 25% or more of the Fund's net asset value, provide:

    c. Credit Spread Risk (SDV01, CR01 or CS01). Provide the change in value of the portfolio resulting from a 1 basis point change in credit spreads where the shift is applied to the option adjusted spread, aggregated by investment grade and non-investment grade exposures, for each of the following maturities: 3 month, 1 year, 5 years, 10 years, and 30 years.

    Investment grade.
    Maturity period.
    3 month.
     
    1 year.
     
    5 years.
     
    10 years.
     
    30 years.
     
    Non-Investment grade.
    Maturity period.
    3 month.
     
    1 year.
     
    5 years.
     
    10 years.
     
    30 years.
     

    For purposes of Item B.3., calculate value as the sum of the absolute values of:
    (i) the value of each debt security,
    (ii) the notional value of each swap, including, but not limited to, total return swaps, interest rate swaps, and credit default swaps, for which the underlying reference asset or assets are debt securities or an interest rate;
    (iii) the notional value of each futures contract for which the underlying reference asset or assets are debt securities or an interest rate; and
    (iv) the delta-adjusted notional value of any option for which the underlying reference asset is an asset described in clause (i),(ii), or (iii).

    Report zero for maturities to which the Fund has no exposure. For exposures that fall between any of the listed maturities in (a) and (b), use linear interpolation to approximate exposure to each maturity listed above. For exposures outside of the range of maturities listed above, include those exposures in the nearest maturity.


    Item B.4. Securities lending.

    a. For each borrower in any securities lending transaction, provide the following information:

    b. Did any securities lending counterparty provide any non-cash collateral? Radio button not checked Yes Radio button checked No

    Item B.5. Return information.

    a. Monthly total returns of the Fund for each of the preceding three months. If the Fund is a Multiple Class Fund, report returns for each class. Such returns shall be calculated in accordance with the methodologies outlined in Item 26(b) (1) of Form N-1A, Instruction 13 to sub-Item 1 of Item 4 of Form N-2, or Item 26(b) (i) of Form N-3, as applicable.

    Monthly Total Return Record: 1
    Monthly total returns of the Fund for each of the preceding three months – Month 1.
    0.06000000 
    Monthly total returns of the Fund for each of the preceding three months – Month 2.
    -0.59000000 
    Monthly total returns of the Fund for each of the preceding three months – Month 3.
    -6.10000000 
    b. Class identification number(s) (if any) of the Class(es) for which returns are reported.
     

    c. For each of the preceding three months, monthly net realized gain (loss) and net change in unrealized appreciation (or depreciation) attributable to derivatives for each of the following categories: commodity contracts, credit contracts, equity contracts, foreign exchange contracts, interest rate contracts, and other contracts. Within each such asset category, further report the same information for each of the following types of derivatives instrument: forward, future, option, swaption, swap, warrant, and other. Report in U.S. dollars. Losses and depreciation shall be reported as negative numbers.

    Asset category.
    Equity Contracts
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    108366.80000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 
    Instrument type.
    Option
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    0.00000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 
    Instrument type.
    Warrant
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    0.00000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 
    Instrument type.
    Other
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    108366.80000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 
    Asset category.
    Other Contracts
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    0.00000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 
    Instrument type.
    Warrant
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    0.00000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 

    d. For each of the preceding three months, monthly net realized gain (loss) and net change in unrealized appreciation (or depreciation) attributable to investment other than derivatives. Report in U.S. dollars. Losses and depreciation shall be reported as negative numbers.
    Month 1


    Monthly net realized gain(loss) – Month 1
    21427960.33000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    -17983797.47000000 
    Month 2
    Monthly net realized gain(loss) – Month 2
    30282364.91000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    -29855492.56000000 
    Month 3
    Monthly net realized gain(loss) – Month 3
    1888726.87000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    -38500316.48000000 

    Item B.6. Flow information.

    Provide the aggregate dollar amounts for sales and redemptions/repurchases of Fund shares during each of the preceding three months. If shares of the Fund are held in omnibus accounts, for purposes of calculating the Fund's sales, redemptions, and repurchases, use net sales or redemptions/repurchases from such omnibus accounts. The amounts to be reported under this Item should be after any front-end sales load has been deducted and before any deferred or contingent deferred sales load or charge has been deducted. Shares sold shall include shares sold by the Fund to a registered unit investment trust. For mergers and other acquisitions, include in the value of shares sold any transaction in which the Fund acquired the assets of another investment company or of a personal holding company in exchange for its own shares. For liquidations, include in the value of shares redeemed any transaction in which the Fund liquidated all or part of its assets. Exchanges are defined as the redemption or repurchase of shares of one Fund or series and the investment of all or part of the proceeds in shares of another Fund or series in the same family of investment companies.
    Month 1
    a. Total net asset value of shares sold (including exchanges but excluding reinvestment of dividends and distributions).
    0.00000000 
    b. Total net asset value of shares sold in connection with reinvestments of dividends and distributions.
    0.00000000 
    c. Total net asset value of shares redeemed or repurchased, including exchanges.
    0.00000000 
    Month 2
    a. Total net asset value of shares sold (including exchanges but excluding reinvestment of dividends and distributions).
    0.00000000 
    b. Total net asset value of shares sold in connection with reinvestments of dividends and distributions.
    0.00000000 
    c. Total net asset value of shares redeemed or repurchased, including exchanges.
    0.00000000 
    Month 3
    a. Total net asset value of shares sold (including exchanges but excluding reinvestment of dividends and distributions).
    0.00000000 
    b. Total net asset value of shares sold in connection with reinvestments of dividends and distributions.
    8948343.57000000 
    c. Total net asset value of shares redeemed or repurchased, including exchanges.
    0.00000000 

    Item B.7. Highly Liquid Investment Minimum information.

    a. If applicable, provide the Fund's current Highly Liquid Investment Minimum.
     
    b. If applicable, provide the number of days that the Fund's holdings in Highly Liquid Investments fell below the Fund's Highly Liquid Investment Minimum during the reporting period.
     
    c. Did the Fund's Highly Liquid Investment Minimum change during the reporting period? Yes is not checked Yes No is not checked No N/A is not checked N/A

    Item B.8. Derivatives Transactions.

    For portfolio investments of open-end management investment companies, provide the percentage of the Fund's Highly Liquid Investments that it has pledged as margin or collateral in connection with derivatives transactions that are classified among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]:

    (1) Moderately Liquid Investments
    (2) Less Liquid Investments
    (3) Illiquid Investments

    For purposes of Item B.8, when computing the required percentage, the denominator should only include assets (and exclude liabilities) that are categorized by the Fund as Highly Liquid Investments.

    Classification
     

    Item B.9. Derivatives Exposure for limited derivatives users.

    If the Fund is excepted from the rule 18f-4 [17 CFR 270.18f-4] program requirement and limit on fund leverage risk under rule 18f-4(c)(4) [17 CFR 270.18f-4(c)(4)], provide the following information:

    a. Derivatives exposure (as defined in rule 18f-4(a) [17 CFR 270.18f-4(a)]), reported as a percentage of the Fund’s net asset value.
     
    b. Exposure from currency derivatives that hedge currency risks, as provided in rule 18f-4(c)(4)(i)(B) [17 CFR 270.18f-4(c)(4)(i)(B)], reported as a percentage of the Fund's net asset value.
     
    c. Exposure from interest rate derivatives that hedge interest rate risks, as provided in rule 18f-4(c)(4)(i)(B) [17 CFR 270.18f-4(c)(4)(i)(B)], reported as a percentage of the Fund's net asset value.
     
    d. The number of business days, if any, in excess of the five-business-day period described in rule 18f-4(c)(4)(ii) [17 CFR 270.18f-4(c)(4)(ii)], that the Fund’s derivatives exposure exceeded 10 percent of its net assets during the reporting period.
     

    Item B.10. VaR information.

    For Funds subject to the limit on fund leverage risk described in rule 18f-4(c)(2) [17 CFR 270.18f-4(c)(2)], provide the following information, as determined in accordance with the requirement under rule 18f-4(c)(2)(ii) to determine the fund’s compliance with the applicable VaR test at least once each business day:

    a. Median daily VaR during the reporting period, reported as a percentage of the Fund's net asset value.
     
    b. For Funds that were subject to the Relative VaR Test during the reporting period, provide:
    i. As applicable, the name of the Fund’s Designated Index, or a statement that the Fund's Designated Reference Portfolio is the Fund’s Securities Portfolio.
     
    ii. As applicable, the index identifier for the Fund’s Designated Index.
     
    iii. Median VaR Ratio during the reporting period, reported as a percentage of the VaRof the Fund's Designated Reference Portfolio.
     
    c. Backtesting Results. Number of exceptions that the Fund identified as a result of its backtesting of its VaR calculation model (as described in rule 18f-4(c)(1)(iv) [17 CFR 270.18f-4(c)(1)(iv)] during the reporting period.
     

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Ionis Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300SI4ZGLG0BLUZ92 
    c. Title of the issue or description of the investment.
    Ionis Pharmaceuticals Inc 
    d. CUSIP (if any).
    462222100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US4622221004 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    56499.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2562794.64000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.275175090928 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    TScan Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    TScan Therapeutics Inc 
    d. CUSIP (if any).
    89854M101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US89854M1018 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    138057.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    353425.92000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.037948420897 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Charles River Laboratories International Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300BSQ0R4UZ5KX287 
    c. Title of the issue or description of the investment.
    Charles River Laboratories International Inc 
    d. CUSIP (if any).
    159864107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US1598641074 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    34616.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    6784043.68000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.728423498072 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    RAINIER THERAPEUTICS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    RAINIER THERAPEUTICS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    943GSBII3 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    3954.93000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    0.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000000 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ARBOR BIOTECHNOLOGIES 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ARBOR BIOTECHNOLOGIES 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    943KLR905 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    82076.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1359999.32000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.146027282367 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    iShares Biotechnology ETF 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300S7IVD88MPK0066 
    c. Title of the issue or description of the investment.
    iShares Biotechnology ETF 
    d. CUSIP (if any).
    464287556 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US4642875565 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    24569.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3004543.01000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.322606963145 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Registered fund  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    OCULIS HOLDING AG 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    OCULIS HOLDING AG 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    952KVL905 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    78540.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    890643.60000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.095631124628 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Revance Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300N33TFDZHS81H11 
    c. Title of the issue or description of the investment.
    Revance Therapeutics Inc 
    d. CUSIP (if any).
    761330109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US7613301099 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    47455.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    544308.85000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.058444104320 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Alnylam Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900S3ZI14OWRJII50 
    c. Title of the issue or description of the investment.
    Alnylam Pharmaceuticals Inc 
    d. CUSIP (if any).
    02043Q107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US02043Q1076 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    124587.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    22064357.70000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    2.369117502284 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    BioNTech SE 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    894500UZJ5LG1F8J1U58 
    c. Title of the issue or description of the investment.
    BioNTech SE 
    d. CUSIP (if any).
    09075V102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US09075V1026 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    66396.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7213261.44000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.774509920407 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    GERMANY  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Rallybio Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Rallybio Corp 
    d. CUSIP (if any).
    75120L100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US75120L1008 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    755076.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2544606.12000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.273222133962 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Vertex Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    54930015RAQRRZ5ZGJ91 
    c. Title of the issue or description of the investment.
    Vertex Pharmaceuticals Inc 
    d. CUSIP (if any).
    92532F100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US92532F1003 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    194177.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    67523109.98000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    7.250162630491 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Johnson & Johnson 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300G0CFPGEF6X2043 
    c. Title of the issue or description of the investment.
    Johnson & Johnson 
    d. CUSIP (if any).
    478160104 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US4781601046 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    93399.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    14546894.25000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.561944482597 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    BioCryst Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300Z0INP1Z5NP6J59 
    c. Title of the issue or description of the investment.
    BioCryst Pharmaceuticals Inc 
    d. CUSIP (if any).
    09058V103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US09058V1035 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    370637.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2624109.96000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.281758704181 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    UnitedHealth Group Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300GHBMY8T5GXDE41 
    c. Title of the issue or description of the investment.
    UnitedHealth Group Inc 
    d. CUSIP (if any).
    91324P102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US91324P1021 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    24166.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    12184255.54000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.308260745434 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Mereo Biopharma Group PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    213800U8JQHIJOS5AS09 
    c. Title of the issue or description of the investment.
    Mereo Biopharma Group PLC 
    d. CUSIP (if any).
    589492107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US5894921072 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1063799.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1372300.71000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.147348120197 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Intercept Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    254900JMB8TX5P688V24 
    c. Title of the issue or description of the investment.
    Intercept Pharmaceuticals Inc 
    d. CUSIP (if any).
    45845P108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US45845P1084 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    33437.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    619921.98000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.066562917119 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Caribou Biosciences Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Caribou Biosciences Inc 
    d. CUSIP (if any).
    142038108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US1420381089 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    385660.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1843454.80000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.197937374417 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CURASEN THERAPEUTICS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    CURASEN THERAPEUTICS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    937CYMII9 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    846390.07000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    846390.07000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.090879487899 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2024-08-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    8.00000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    HOTSPOT THERAPEUTICS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    HOTSPOT THERAPEUTICS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944AJFII6 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    632394.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1699432.40000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.182473249279 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    G1 Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900TC35UPZQYRKW13 
    c. Title of the issue or description of the investment.
    G1 Therapeutics Inc 
    d. CUSIP (if any).
    3621LQ109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US3621LQ1099 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    200492.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    288708.48000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.030999511625 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ARKUDA THERAPEUTICS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ARKUDA THERAPEUTICS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944DUTII7 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1044322.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    536259.35000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.057579804910 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    AbbVie Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    FR5LCKFTG8054YNNRU85 
    c. Title of the issue or description of the investment.
    AbbVie Inc 
    d. CUSIP (if any).
    00287Y109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US00287Y1091 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    115116.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    17159190.96000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.842434762031 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ARKUDA THERAPEUTICS,INC SER A. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ARKUDA THERAPEUTICS,INC SER A. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    964NDQ904 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2353932.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    235.39000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000025274543 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Thermo Fisher Scientific Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    HCHV7422L5HDJZCRFL38 
    c. Title of the issue or description of the investment.
    Thermo Fisher Scientific Inc 
    d. CUSIP (if any).
    883556102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US8835561023 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    27187.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    13761243.79000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.477586792209 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CONTRA CHINOOK THERAPE 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300X0O3003W5QYQ48 
    c. Title of the issue or description of the investment.
    CONTRA CHINOOK THERAPE 
    d. CUSIP (if any).
    169CVR016 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US169CVR0169 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    91800.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    150552.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.016165228240 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Other  
    If "other", provide a brief description.
    rights 

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    N/A 
    LEI (if any) of counterparty.
    N/A 

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Chinook Therapeutics, Inc. 
    Title of issue.
    Chinook Therapeutics, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    16961L106 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US16961L1061 
    ii. Termination or maturity (if any).
    2499-12-31 
    iii. Notional amount(s).
    91800.00000000 
    ISO Currency Code.
    United States Dollar  
    iv. Delta (if applicable).
    XXXX 
    Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    114750.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Agilent Technologies Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    QUIX8Y7A2WP0XRMW7G29 
    c. Title of the issue or description of the investment.
    Agilent Technologies Inc 
    d. CUSIP (if any).
    00846U101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US00846U1016 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    10336.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1155771.52000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.124098719477 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    BioMarin Pharmaceutical Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    NSLL8ITTRR0J5HEMR848 
    c. Title of the issue or description of the investment.
    BioMarin Pharmaceutical Inc 
    d. CUSIP (if any).
    09061G101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US09061G1013 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    163098.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    14430911.04000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.549491010961 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    IO LIGHT HOLDINIGS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    IO LIGHT HOLDINIGS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    966MVK907 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    421634.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    640377.72000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.068759312423 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Sage Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493000JX4BJS9W6CN35 
    c. Title of the issue or description of the investment.
    Sage Therapeutics Inc 
    d. CUSIP (if any).
    78667J108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US78667J1088 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    42028.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    864936.24000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.092870846838 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Curasen Therapeutics, Inc. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    CURASEN THERAPEUTICS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    934MMA908 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    18203119.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    8728395.56000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.937194500253 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Adaptive Biotechnologies Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300ZTF7OT1FW66Q96 
    c. Title of the issue or description of the investment.
    Adaptive Biotechnologies Corp 
    d. CUSIP (if any).
    00650F109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US00650F1093 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    216209.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1178339.05000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.126521864127 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    QUELL THERAPEUTICS 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    QUELL THERAPEUTICS 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944BAGII1 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1553631.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3229998.85000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.346814845550 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Afferent Milestone Interest 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    AFFERENT MILESTONE INTEREST 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    930LUG902 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    26208.04000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    280950.19000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.030166480323 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    OTHER 
    If "other", provide a brief description.
    Milestone Interest 
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Praxis Precision Medicines Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Praxis Precision Medicines Inc 
    d. CUSIP (if any).
    74006W108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US74006W1080 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    51406.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    87904.26000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.009438548981 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Seagen Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Seagen Inc 
    d. CUSIP (if any).
    81181C104 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US81181C1045 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    73111.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    15510498.65000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.665409631248 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Medtronic PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300GX3ZBSQWUXY261 
    c. Title of the issue or description of the investment.
    Medtronic PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    IE00BTN1Y115 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    52381.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4104575.16000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.440720776159 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    RECODE THERAPEUTICS 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    RECODE THERAPEUTICS 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    943HUY907 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    319138.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2946664.98000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.316392422222 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ETHISMOS RESEARCH, INC. MILEST 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ETHISMOS RESEARCH, INC. MILEST 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    932TYG909 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1180.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    0.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000000 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    OTHER 
    If "other", provide a brief description.
    Milestone Interest 
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    HIBERCELL,INC. SERIES C 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    HIBERCELL,INC. SERIES C 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    902ATSII7 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1529261.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    708965.40000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.076123781190 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Ascendis Pharma A/S 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300B66JN3W3J8GH73 
    c. Title of the issue or description of the investment.
    Ascendis Pharma A/S 
    d. CUSIP (if any).
    04351P101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US04351P1012 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    92961.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    8704868.04000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.934668278544 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    DENMARK  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Intellia Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493002T5BCPE5DZC723 
    c. Title of the issue or description of the investment.
    Intellia Therapeutics Inc 
    d. CUSIP (if any).
    45826J105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US45826J1051 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    103664.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3277855.68000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.351953379610 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Zoetis Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300HD9Q1LOC9KLJ48 
    c. Title of the issue or description of the investment.
    Zoetis Inc 
    d. CUSIP (if any).
    98978V103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US98978V1035 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    5547.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    965067.06000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.103622198924 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Boston Scientific Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    Y6ZDD9FP4P8JSSJMW954 
    c. Title of the issue or description of the investment.
    Boston Scientific Corp 
    d. CUSIP (if any).
    101137107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US1011371077 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    183360.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    9681408.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.039522357796 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Zimmer Biomet Holdings Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    2P2YLDVPES3BXQ1FRB91 
    c. Title of the issue or description of the investment.
    Zimmer Biomet Holdings Inc 
    d. CUSIP (if any).
    98956P102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US98956P1021 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    24137.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2708654.14000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.290836471107 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Impact Biomedicines Milestone 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Impact Biomedicines Milestone Preferred Stock 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    ACI006C40 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    78177.95000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1081982.83000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.116175802376 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    OTHER 
    If "other", provide a brief description.
    Milestone Interest 
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Elevance Health Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    8MYN82XMYQH89CTMTH67 
    c. Title of the issue or description of the investment.
    Elevance Health Inc 
    d. CUSIP (if any).
    036752103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0367521038 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    18435.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    8026967.70000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.861880047763 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Marinus Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300NCT4OJF7JV1084 
    c. Title of the issue or description of the investment.
    Marinus Pharmaceuticals Inc 
    d. CUSIP (if any).
    56854Q200 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US56854Q2003 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    385154.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3100489.70000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.332909052409 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Apellis Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    254900HS0ZFRXXSB9D42 
    c. Title of the issue or description of the investment.
    Apellis Pharmaceuticals Inc 
    d. CUSIP (if any).
    03753U106 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US03753U1060 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    118059.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4490964.36000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.482208565147 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Biogen Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    W8J5WZB5IY3K0NDQT671 
    c. Title of the issue or description of the investment.
    Biogen Inc 
    d. CUSIP (if any).
    09062X103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US09062X1037 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    132773.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    34123988.73000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    3.663996933299 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Madrigal Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CHIMT2EUSNJB60 
    c. Title of the issue or description of the investment.
    Madrigal Pharmaceuticals Inc 
    d. CUSIP (if any).
    558868105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US5588681057 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    10540.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1539261.60000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.165275221093 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Inspire Medical Systems Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300XQQCQ7HCJKTW25 
    c. Title of the issue or description of the investment.
    Inspire Medical Systems Inc 
    d. CUSIP (if any).
    457730109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US4577301090 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    21488.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4264078.72000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.457847160747 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    FUSION PHARMACEUTICALS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    FUSION PHARMACEUTICALS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944WZK007 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    7593.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    17767.62000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.001907763647 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    United Therapeutics Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5299005C4HZL4UWROC14 
    c. Title of the issue or description of the investment.
    United Therapeutics Corp 
    d. CUSIP (if any).
    91307C102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US91307C1027 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    17837.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4028843.19000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.432589203146 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Insulet Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300TZTYD2PYN92D43 
    c. Title of the issue or description of the investment.
    Insulet Corp 
    d. CUSIP (if any).
    45784P101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US45784P1012 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    18268.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2913563.32000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.312838195848 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Becton Dickinson & Co 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    ICE2EP6D98PQUILVRZ91 
    c. Title of the issue or description of the investment.
    Becton Dickinson & Co 
    d. CUSIP (if any).
    075887109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0758871091 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    3506.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    906406.18000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.097323601004 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Endo International PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493007TBMWZWGZIB256 
    c. Title of the issue or description of the investment.
    Endo International PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    IE00BJ3V9050 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    465507.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3770.61000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000404861916 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Moderna Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300EI6OKH5K5Q2G38 
    c. Title of the issue or description of the investment.
    Moderna Inc 
    d. CUSIP (if any).
    60770K107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US60770K1079 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    182904.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    18892154.16000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    2.028508315758 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Stryker Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493002F0SC4JTBU5137 
    c. Title of the issue or description of the investment.
    Stryker Corp 
    d. CUSIP (if any).
    863667101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US8636671013 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    12890.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3522450.30000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.378216251301 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    HIBERCELL, INC. SERIES B 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    HIBERCELL, INC. SERIES B 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    942SPU007 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2773472.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1285781.62000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.138058301151 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    AstraZeneca PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    PY6ZZQWO2IZFZC3IOL08 
    c. Title of the issue or description of the investment.
    AstraZeneca PLC 
    d. CUSIP (if any).
    046353108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0463531089 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    494952.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    33518149.44000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    3.598946117634 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    AMOLYT PHARMA SAS 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    969500V716C9UYA3FR49 
    c. Title of the issue or description of the investment.
    AMOLYT PHARMA SAS 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    952GJX001 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1602836.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    Euro Member Countries  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3626440.81000000 
    Exchange rate.
    0.94585000 
    Percentage value compared to net assets of the Fund.
    0.389382030095 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    FRANCE  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Incendia Therapeutics, Inc. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Incendia Therapeutics, Inc. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    943CVBII8 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1769383.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3399993.29000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.365067667978 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Denali Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300ZTQ2HO18L3Q830 
    c. Title of the issue or description of the investment.
    Denali Therapeutics Inc 
    d. CUSIP (if any).
    24823R105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US24823R1059 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    214498.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4425093.74000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.475135835415 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Illumina Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    SQ95QG8SR5Q56LSNF682 
    c. Title of the issue or description of the investment.
    Illumina Inc 
    d. CUSIP (if any).
    452327109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US4523271090 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    142483.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    19560066.24000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    2.100224076544 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Sutro Biopharma Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493005U6P15VD25P851 
    c. Title of the issue or description of the investment.
    Sutro Biopharma Inc 
    d. CUSIP (if any).
    869367102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US8693671021 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    69389.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    240779.83000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.025853266032 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    INVETX, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    INVETX, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    966YPV904 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    7187500.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4816343.75000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.517145544424 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Mirati Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900GYRW59IDQV6N54 
    c. Title of the issue or description of the investment.
    Mirati Therapeutics Inc 
    d. CUSIP (if any).
    60468T105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US60468T1051 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    42638.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1857311.28000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.199425187012 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ABCURO, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ABCURO, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    902JKGII3 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    266408.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1462500.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.157033093562 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Akero Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300SI3KG74LBE2955 
    c. Title of the issue or description of the investment.
    Akero Therapeutics Inc 
    d. CUSIP (if any).
    00973Y108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US00973Y1082 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    40050.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2025729.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.217508712197 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Guardant Health Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    254900M8C3E5VC8BR186 
    c. Title of the issue or description of the investment.
    Guardant Health Inc 
    d. CUSIP (if any).
    40131M109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US40131M1099 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    173673.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5147667.72000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.552720811419 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Precision BioSciences Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300I5QGRS3BLHZH41 
    c. Title of the issue or description of the investment.
    Precision BioSciences Inc 
    d. CUSIP (if any).
    74019P108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US74019P1084 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    154807.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    52835.63000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.005673123028 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Intra-Cellular Therapies Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5299002U2KGF193IJA20 
    c. Title of the issue or description of the investment.
    Intra-Cellular Therapies Inc 
    d. CUSIP (if any).
    46116X101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US46116X1019 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    19220.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1001169.80000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.107498660427 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Perrigo Co PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300IFOQS6R1QLY196 
    c. Title of the issue or description of the investment.
    Perrigo Co PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    IE00BGH1M568 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    7050.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    225247.50000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.024185512302 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Incyte Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300Z4WN6JVZ3T4680 
    c. Title of the issue or description of the investment.
    Incyte Corp 
    d. CUSIP (if any).
    45337C102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US45337C1027 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    171457.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    9905070.89000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.063537725681 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    HOTSPOT THERAPEUTICS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    HOTSPOT THERAPEUTICS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    966LWP907 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2875000.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7725987.50000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.829562884066 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Amylyx Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Amylyx Pharmaceuticals Inc 
    d. CUSIP (if any).
    03237H101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US03237H1014 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    136497.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2499260.07000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.268353190022 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Oculis Holding AG 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5067005370C2KK324336 
    c. Title of the issue or description of the investment.
    Oculis Holding AG 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    CH1242303498 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    479405.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5436452.70000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.583728537083 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    SWITZERLAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Intuitive Surgical Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    54930052SRG011710797 
    c. Title of the issue or description of the investment.
    Intuitive Surgical Inc 
    d. CUSIP (if any).
    46120E602 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US46120E6023 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    34571.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    10104757.59000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.084978696788 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Theseus Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Theseus Pharmaceuticals Inc 
    d. CUSIP (if any).
    88369M101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US88369M1018 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    51750.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    139207.50000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.014947134613 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Amgen Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    62QBXGPJ34PQ72Z12S66 
    c. Title of the issue or description of the investment.
    Amgen Inc 
    d. CUSIP (if any).
    031162100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0311621009 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    257888.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    69309978.88000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    7.442024203931 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ENDEAVOR BIOMEDICINES, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ENDEAVOR BIOMEDICINES, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944DTH003 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    657322.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3099996.28000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.332856072396 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Karuna Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Karuna Therapeutics Inc 
    d. CUSIP (if any).
    48576A100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US48576A1007 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    39143.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    6618689.87000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.710668954266 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Medpace Holdings Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300H8TYEUVTW14A54 
    c. Title of the issue or description of the investment.
    Medpace Holdings Inc 
    d. CUSIP (if any).
    58506Q109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US58506Q1094 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    12199.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2953743.87000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.317152504270 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Pyxis Oncology Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Pyxis Oncology Inc 
    d. CUSIP (if any).
    747324101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US7473241013 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    481646.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    958475.54000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.102914447281 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Abbott Laboratories 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    HQD377W2YR662HK5JX27 
    c. Title of the issue or description of the investment.
    Abbott Laboratories 
    d. CUSIP (if any).
    002824100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0028241000 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    114588.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    11097847.80000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.191609826950 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Vaxcyte Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    254900M7NMHTGASX8D95 
    c. Title of the issue or description of the investment.
    Vaxcyte Inc 
    d. CUSIP (if any).
    92243G108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US92243G1085 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    132313.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    6745316.74000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.724265268197 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Bridgebio Pharma Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    54930028YG89VTY2J114 
    c. Title of the issue or description of the investment.
    Bridgebio Pharma Inc 
    d. CUSIP (if any).
    10806X102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US10806X1028 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    124341.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3278872.17000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.352062523247 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    BIOTHERYX, INC. SERIES E 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    BIOTHERYX, INC. SERIES E 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    942TVB901 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1295238.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2039999.85000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.219041016965 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CONTRA SPECTRUM PHARMA 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300COU30WSP3O5I07 
    c. Title of the issue or description of the investment.
    CONTRA SPECTRUM PHARMA 
    d. CUSIP (if any).
    847CVR016 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    847CVR016 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    79790.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    0.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000000 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Other  
    If "other", provide a brief description.
    rights 

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    N/A 
    LEI (if any) of counterparty.
    N/A 

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Spectrum Pharmaceuticals, Inc. 
    Title of issue.
    Spectrum Pharmaceuticals, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    84763A108 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US84763A1088 
    ii. Termination or maturity (if any).
    2499-12-31 
    iii. Notional amount(s).
    79790.00000000 
    ISO Currency Code.
    United States Dollar  
    iv. Delta (if applicable).
    XXXX 
    Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    -6383.20000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Dexcom Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300YSK3QDSFR5EU59 
    c. Title of the issue or description of the investment.
    Dexcom Inc 
    d. CUSIP (if any).
    252131107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US2521311074 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    46279.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4317830.70000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.463618675075 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Fixed Income Clearing Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300H47WTHXPU08X20 
    c. Title of the issue or description of the investment.
    FIXED INC CLEARING CORP.REPO 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    85748R009 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    32737000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    32737000.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    3.515071715516 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Repurchase agreement  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is checked Yes No is not checked No
    Value
    Fixed Income Clearing Corp 
    c. Tri-party? Yes is not checked Yes No is checked No
    d. Repurchase rate.
    1.60000000 
    e. Maturity date.
    2023-10-02 

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    i. Principal amount.
    33992700.00000000 
    ISO Currency Code
    United States Dollar  
    ii. Value of collateral.
    33391823.28000000 
    ISO Currency Code
    United States Dollar  
    iii. Category of investments that most closely represents the collateral, selected from among the following (asset-backed securities; agency collateralized mortgage obligations; agency debentures and agency strips; agency mortgage-backed securities; private label collateralized mortgage obligations; corporate debt securities; equities; money market; U.S. Treasuries (including strips); other instrument). If "other instrument," include a brief description, including, if applicable, whether it is a collateralized debt obligation, municipal debt, whole loan, or international debt.
    U.S. Treasuries (including strips)  

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    NEUROVANCE MILESTONE INTEREST 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    NEUROVANCE MILESTONE INTEREST 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    931UVM907 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    49006.12000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    12658770.86000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.359210905189 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    OTHER 
    If "other", provide a brief description.
    Milestone Interest 
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Pfizer Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    765LHXWGK1KXCLTFYQ30 
    c. Title of the issue or description of the investment.
    Pfizer Inc 
    d. CUSIP (if any).
    717081103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US7170811035 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    223242.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7404937.14000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.795090725967 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Jazz Pharmaceuticals PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    635400GAUMJCLEZRRV50 
    c. Title of the issue or description of the investment.
    Jazz Pharmaceuticals PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    IE00B4Q5ZN47 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    22124.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2863730.56000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.307487500147 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Molina Healthcare Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300NQQCEQ46YHZ591 
    c. Title of the issue or description of the investment.
    Molina Healthcare Inc 
    d. CUSIP (if any).
    60855R100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US60855R1005 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    18161.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5954810.29000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.639386175325 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Sarepta Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300IKDPIED8J8IG21 
    c. Title of the issue or description of the investment.
    Sarepta Therapeutics Inc 
    d. CUSIP (if any).
    803607100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US8036071004 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    113095.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    13709375.90000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.472017578381 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Edwards Lifesciences Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    YA13X31F3V31L8TMPR58 
    c. Title of the issue or description of the investment.
    Edwards Lifesciences Corp 
    d. CUSIP (if any).
    28176E108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US28176E1082 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    75377.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5222118.56000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.560714825589 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Argenx SE 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    7245009C5FZE6G9ODQ71 
    c. Title of the issue or description of the investment.
    Argenx SE 
    d. CUSIP (if any).
    04016X101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US04016X1019 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    26078.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    12820727.14000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.376600645818 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    NETHERLANDS  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    INNOVACARE INC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    INNOVACARE INC 
    d. CUSIP (if any).
    457ESC010 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    457ESC010 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    222222.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    28422.19000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.003051777382 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    TETRAPHASE PHARMACEUTICALS INC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    TETRAPHASE PHARMACEUTICALS INC 
    d. CUSIP (if any).
    881CVR013 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US881CVR0133 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    28747.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1724.82000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000185199193 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Other  
    If "other", provide a brief description.
    rights 

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    N/A 
    LEI (if any) of counterparty.
    N/A 

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Tetraphase Pharmaceuticals Inc 
    Title of issue.
    Tetraphase Pharmaceuticals Inc 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    88165N105 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US88165N1054 
    ii. Termination or maturity (if any).
    2099-12-31 
    iii. Notional amount(s).
    28747.00000000 
    ISO Currency Code.
    United States Dollar  
    iv. Delta (if applicable).
    XXXX 
    Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    -4024.58000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    DYNACURE 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Dynacure SA 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    935QPK903 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    243458.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    Euro Member Countries  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1572689.52000000 
    Exchange rate.
    0.94585000 
    Percentage value compared to net assets of the Fund.
    0.168864479000 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    FRANCE  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Fusion Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Fusion Pharmaceuticals Inc 
    d. CUSIP (if any).
    36118A100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    CA36118A1003 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    15186.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    39483.60000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.004239474771 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    CANADA (FEDERAL LEVEL)  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    I-Mab 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300L1A5T19703RR64 
    c. Title of the issue or description of the investment.
    I-Mab 
    d. CUSIP (if any).
    44975P103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US44975P1030 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    53885.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    71128.20000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.007637252161 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    CAYMAN ISLANDS  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Assertio Holdings Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Assertio Holdings Inc 
    d. CUSIP (if any).
    04546C205 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US04546C2052 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    14226.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    36418.56000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.003910372061 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Ultragenyx Pharmaceutical Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900EV44GVDN1DCX77 
    c. Title of the issue or description of the investment.
    Ultragenyx Pharmaceutical Inc 
    d. CUSIP (if any).
    90400D108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US90400D1081 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    45126.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1608741.90000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.172735533196 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    INVETX, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    INVETX, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944KFX007 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    3089091.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2069999.88000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.222262211849 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    THERACHON MILESTONE INTEREST 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    THERACHON MILESTONE INTEREST 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    964WMT908 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    32777.35000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    0.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000000 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Arcutis Biotherapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Arcutis Biotherapeutics Inc 
    d. CUSIP (if any).
    03969K108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US03969K1088 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    86869.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    461274.39000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.049528440644 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Tenet Healthcare Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    0W9AIBT6U6ADJ2I8HK17 
    c. Title of the issue or description of the investment.
    Tenet Healthcare Corp 
    d. CUSIP (if any).
    88033G407 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US88033G4073 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    43846.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2889012.94000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.310202146536 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Neurocrine Biosciences Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300FECER0XBN49756 
    c. Title of the issue or description of the investment.
    Neurocrine Biosciences Inc 
    d. CUSIP (if any).
    64125C109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US64125C1099 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    43499.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4893637.50000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.525444810527 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Exelixis Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    254900PJQB59O2O95R37 
    c. Title of the issue or description of the investment.
    Exelixis Inc 
    d. CUSIP (if any).
    30161Q104 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US30161Q1040 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    584656.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    12774733.60000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.371662178898 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Affimed NV 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493004V4FSXT1D04610 
    c. Title of the issue or description of the investment.
    Affimed NV 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    NL0010872420 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    367414.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    175587.15000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.018853328789 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    NETHERLANDS  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    SPDR S&P Biotech ETF 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300Y3ODFMPD5XXL58 
    c. Title of the issue or description of the investment.
    SPDR S&P Biotech ETF 
    d. CUSIP (if any).
    78464A870 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US78464A8707 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    57000.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4162140.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.446901688915 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Registered fund  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    HCA Healthcare Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900PH4ZGUH2MNEU89 
    c. Title of the issue or description of the investment.
    HCA Healthcare Inc 
    d. CUSIP (if any).
    40412C101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US40412C1018 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    16232.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3992747.36000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.428713483591 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Avantor Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Avantor Inc 
    d. CUSIP (if any).
    05352A100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US05352A1007 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    129493.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2729712.44000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.293097565120 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    McKesson Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300WZWOM80UCFSF54 
    c. Title of the issue or description of the investment.
    McKesson Corp 
    d. CUSIP (if any).
    58155Q103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US58155Q1031 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    12176.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5294733.60000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.568511724304 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Humana Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900YLDW34GJAO4J06 
    c. Title of the issue or description of the investment.
    Humana Inc 
    d. CUSIP (if any).
    444859102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US4448591028 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    4847.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2358162.44000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.253203106376 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    PRIOTHERA LIMITED 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    PRIOTHERA LIMITED 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    967FAN908 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    346666.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    Euro Member Countries  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2565588.62000000 
    Exchange rate.
    0.94585000 
    Percentage value compared to net assets of the Fund.
    0.275475089098 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Cytokinetics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300BE5DY1HW7IHA64 
    c. Title of the issue or description of the investment.
    Cytokinetics Inc 
    d. CUSIP (if any).
    23282W605 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US23282W6057 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    132081.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3891106.26000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.417799968127 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Danaher Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    S4BKK9OTCEWQ3YHPFM11 
    c. Title of the issue or description of the investment.
    Danaher Corp 
    d. CUSIP (if any).
    235851102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US2358511028 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    44068.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    10933270.80000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.173938691607 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Regeneron Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300RCBFWIRX3HYQ56 
    c. Title of the issue or description of the investment.
    Regeneron Pharmaceuticals Inc 
    d. CUSIP (if any).
    75886F107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US75886F1075 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    86913.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    71525922.48000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    7.679956838917 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    VYNE Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    VYNE Therapeutics Inc 
    d. CUSIP (if any).
    92941V308 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US92941V3087 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    5265.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    21060.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.002261276547 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    AMPHIVENA MILESTONE INTEREST 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    AMPHIVENA MILESTONE INTEREST 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944ZQW905 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    100.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    0.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000000 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Immunovant Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Immunovant Inc 
    d. CUSIP (if any).
    45258J102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US45258J1025 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    314275.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    12065017.25000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.295457765912 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Teva Pharmaceutical Industries Ltd 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300BAFGM4RC74ZJ94 
    c. Title of the issue or description of the investment.
    Teva Pharmaceutical Industries Ltd 
    d. CUSIP (if any).
    881624209 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US8816242098 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    291666.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2974993.20000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.319434109758 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    ISRAEL  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    HIBERCELL, INC. SERIES C 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    HIBERCELL, INC. SERIES C 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    ACI2JX2G1 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1529261.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    0.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000000 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Warrant  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    N/A 
    LEI (if any) of counterparty.
    N/A 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is not checked Written Purchased is checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    HiberCell, Inc. 
    Title of issue.
    HiberCell, Inc. 

    At least one of the following other identifiers:

    Identifier.
    Other identifier (if CUSIP, ISIN, and ticker are not available)
    Other identifier (if CUSIP, ISIN, and ticker are not available).
    902ATSII7 
    If other identifier provided, indicate the type of identifier used.
    Internal Identifier 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    1.00000000 
    v. Exercise price or rate.
    0.46360000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2028-09-15 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    0.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Alkermes PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Alkermes PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    IE00B56GVS15 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    173907.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4871135.07000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.523028655863 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Merck & Co Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    4YV9Y5M8S0BRK1RP0397 
    c. Title of the issue or description of the investment.
    Merck & Co Inc 
    d. CUSIP (if any).
    58933Y105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US58933Y1055 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    114534.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    11791275.30000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.266065256342 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    89bio Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    89bio Inc 
    d. CUSIP (if any).
    282559103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US2825591033 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    56488.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    872174.72000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.093648064552 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Scholar Rock Holding Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300Z1FLPGL4OWJ459 
    c. Title of the issue or description of the investment.
    Scholar Rock Holding Corp 
    d. CUSIP (if any).
    80706P103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US80706P1030 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    68117.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    483630.70000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.051928905957 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    West Pharmaceutical Services Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493007NKRGM1RJQ1P16 
    c. Title of the issue or description of the investment.
    West Pharmaceutical Services Inc 
    d. CUSIP (if any).
    955306105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US9553061055 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    5474.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2053899.54000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.220533469150 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Eli Lilly & Co 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    FRDRIPF3EKNDJ2CQJL29 
    c. Title of the issue or description of the investment.
    Eli Lilly & Co 
    d. CUSIP (if any).
    532457108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US5324571083 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    19770.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    10619060.10000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.140200928700 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Galera Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Galera Therapeutics Inc 
    d. CUSIP (if any).
    36338D108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US36338D1081 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    296462.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    51910.50000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.005573788993 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Novavax Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900J4GJHPEPQ23205 
    c. Title of the issue or description of the investment.
    Novavax Inc 
    d. CUSIP (if any).
    670002401 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US6700024010 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    37188.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    269241.12000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.028909241701 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    uniQure NV 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    724500RPCTZLFYJZ3S98 
    c. Title of the issue or description of the investment.
    uniQure NV 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    NL0010696654 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    244086.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1637817.06000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.175857421962 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    NETHERLANDS  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Royalty Pharma PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300FGFN7VOK8BZR03 
    c. Title of the issue or description of the investment.
    Royalty Pharma PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    GB00BMVP7Y09 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    156941.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4259378.74000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.457342509534 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Cercacor Laboratories Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    CERCACOR LABORATORIES INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    574992913 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    160000.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    127079.84000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.013644950703 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Roivant Sciences Ltd 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300DL466NY5J6U724 
    c. Title of the issue or description of the investment.
    Roivant Sciences Ltd 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    BMG762791017 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    563349.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    6579916.32000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.706505719732 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    BERMUDA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Catalent Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Catalent Inc 
    d. CUSIP (if any).
    148806102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US1488061029 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    42400.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1930472.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.207280677056 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    IDEXX Laboratories Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    OGMTXK0LUU1HKV2P0J84 
    c. Title of the issue or description of the investment.
    IDEXX Laboratories Inc 
    d. CUSIP (if any).
    45168D104 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US45168D1046 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    15551.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    6799985.77000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.730135248985 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Baxter International Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    J5OIVXX3P24RJRW5CK77 
    c. Title of the issue or description of the investment.
    Baxter International Inc 
    d. CUSIP (if any).
    071813109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0718131099 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    39600.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1494504.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.160469460827 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Bristol-Myers Squibb Co 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    HLYYNH7UQUORYSJQCN42 
    c. Title of the issue or description of the investment.
    Bristol-Myers Squibb Co 
    d. CUSIP (if any).
    110122108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US1101221083 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    119794.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    6952843.76000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.746548078418 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Xencor Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300V5IF65437JKG30 
    c. Title of the issue or description of the investment.
    Xencor Inc 
    d. CUSIP (if any).
    98401F105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US98401F1057 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    78135.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1574420.25000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.169050312768 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    IMMUNEID, INC. SERIES A 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    IMMUNEID, INC. SERIES A 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    942RVA907 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1020000.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    488070.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.052405567162 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Black Diamond Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Black Diamond Therapeutics Inc 
    d. CUSIP (if any).
    09203E105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US09203E1055 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    90404.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    259459.48000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.027858957127 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Gilead Sciences Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300WTZWR07K8MNV44 
    c. Title of the issue or description of the investment.
    Gilead Sciences Inc 
    d. CUSIP (if any).
    375558103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US3755581036 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    655681.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    49136734.14000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    5.275961278319 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part E: Explanatory Notes (if any)

    The Fund may provide any information it believes would be helpful in understanding the information reported in response to any Item of this Form. The Fund may also explain any assumptions that it made in responding to any Item of this Form. To the extent responses relate to a particular Item, provide the Item number(s), as applicable.

    NPORT-P: Signatures

    The Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Registrant:
    TEKLA HEALTHCARE INVESTORS 
    By(Signature):
    Laura Woodward 
    Name:
    Laura Woodward 
    Title:
    CCO 
    Date:
    2023-10-19 

    Get the next $HQH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HQH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HQH
    Financials

    Live finance-specific insights

    See more
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / August 9, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:ACP)(NYSE:ASGI)(NYSE:AWP)(NYSE:HQH)(NYSE:HQL)(NYSE:IFN)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE:FAX)(NYSE:FCO)(NYSE:IAF)(NYSE:VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on August 30, 2024 to all shareholders of record as of August 23, 2024 (ex-dividend date August 23, 2024). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), the India Fund, Inc. (IFN) and the abrdn Japan Equi

      8/9/24 4:17:00 PM ET
      $ACP
      $ASGI
      $AWP
      $FAX
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / June 28, 2024 / PHILADELPHIA, PA / ACCESSWIRE / June 28, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE:HQH)(NYSE:HQL)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on June 28, 2024, on a per share basis to all shareholders of record as of June 21, 2024 (ex-dividend date June 21, 2024). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and abrdn Japan Equity Fund, Inc. (JEQ) which will pay on June 28, 2024, to al

      6/28/24 4:17:00 PM ET
      $ASGI
      $AWP
      $HQH
      $HQL
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / January 10, 2024 / PHILADELPHIA, PA / ACCESSWIRE / January 10, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI, IFN, JEQ))) (NYSE:HQH, HQL, IAF, THQ, THW))), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on January 10, 2024, on a per share basis to all shareholders of record as of December 29, 2023 (ex-dividend date December 28, 2023). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), the India Fund, Inc. (IFN) and the abrdn Japan Equity Fund, Inc. (JEQ)

      1/10/24 4:17:00 PM ET
      $ACP
      $ASGI
      $HQH
      $HQL
      Investment Managers
      Finance
      Finance Companies
      Finance/Investors Services

    $HQH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Hepp Robert W.

      3 - abrdn Healthcare Investors (0000805267) (Issuer)

      3/20/25 4:36:06 PM ET
      $HQH
      Finance Companies
      Finance
    • SEC Form 3 filed by new insider Gebauer Katie Lynn

      3 - abrdn Healthcare Investors (0000805267) (Issuer)

      3/20/25 4:32:38 PM ET
      $HQH
      Finance Companies
      Finance
    • SEC Form 3 filed by new insider Hasson Heather

      3 - abrdn Healthcare Investors (0000805267) (Issuer)

      3/20/25 4:28:38 PM ET
      $HQH
      Finance Companies
      Finance

    $HQH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by abrdn Healthcare Investors Shares of Beneficial Interest

      SC 13D/A - abrdn Healthcare Investors (0000805267) (Subject)

      11/18/24 4:02:58 PM ET
      $HQH
      Finance Companies
      Finance
    • Amendment: SEC Form SC 13D/A filed by abrdn Healthcare Investors Shares of Beneficial Interest

      SC 13D/A - abrdn Healthcare Investors (0000805267) (Subject)

      10/22/24 4:23:07 PM ET
      $HQH
      Finance Companies
      Finance
    • SEC Form SC 13D/A filed by abrdn Healthcare Investors Shares of Beneficial Interest (Amendment)

      SC 13D/A - abrdn Healthcare Investors (0000805267) (Subject)

      5/3/24 7:15:52 AM ET
      $HQH
      Finance Companies
      Finance

    $HQH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Dimartino Rose bought $18,880 worth of shares (1,000 units at $18.88) (SEC Form 4)

      4 - abrdn Healthcare Investors (0000805267) (Issuer)

      7/18/24 2:54:48 PM ET
      $HQH
      Finance Companies
      Finance
    • Goetz Kathleen bought $8,622 worth of shares (525 units at $16.42), increasing direct ownership by 95% to 1,080 units (SEC Form 4)

      4 - abrdn Healthcare Investors (0000805267) (Issuer)

      4/12/24 9:19:10 AM ET
      $HQH
      Finance Companies
      Finance
    • Goodson Alan R bought $2,742 worth of shares (170 units at $16.13) (SEC Form 4)

      4 - abrdn Healthcare Investors (0000805267) (Issuer)

      1/9/24 12:09:55 PM ET
      $HQH
      Finance Companies
      Finance

    $HQH
    Leadership Updates

    Live Leadership Updates

    See more
    • abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update

      PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.The Funds will continue to be managed in accordance with their existing investment objectives and strategies, pursuing the same investment philosophy and employing the same investment process that has

      3/21/24 7:59:00 AM ET
      $AWP
      $HQH
      $HQL
      $THQ
      Trusts Except Educational Religious and Charitable
      Finance
      Finance Companies
      Investment Managers

    $HQH
    SEC Filings

    See more
    • SEC Form N-CEN filed by abrdn Healthcare Investors Shares of Beneficial Interest

      N-CEN - abrdn Healthcare Investors (0000805267) (Filer)

      12/16/24 11:48:21 AM ET
      $HQH
      Finance Companies
      Finance
    • SEC Form N-CSR filed by abrdn Healthcare Investors Shares of Beneficial Interest

      N-CSR - abrdn Healthcare Investors (0000805267) (Filer)

      12/9/24 1:03:19 PM ET
      $HQH
      Finance Companies
      Finance
    • SEC Form N-PX filed by abrdn Healthcare Investors Shares of Beneficial Interest

      N-PX - abrdn Healthcare Investors (0000805267) (Filer)

      8/30/24 6:11:25 PM ET
      $HQH
      Finance Companies
      Finance

    $HQH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / August 9, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:ACP)(NYSE:ASGI)(NYSE:AWP)(NYSE:HQH)(NYSE:HQL)(NYSE:IFN)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE:FAX)(NYSE:FCO)(NYSE:IAF)(NYSE:VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on August 30, 2024 to all shareholders of record as of August 23, 2024 (ex-dividend date August 23, 2024). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), the India Fund, Inc. (IFN) and the abrdn Japan Equi

      8/9/24 4:17:00 PM ET
      $ACP
      $ASGI
      $AWP
      $FAX
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / June 28, 2024 / PHILADELPHIA, PA / ACCESSWIRE / June 28, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE:HQH)(NYSE:HQL)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on June 28, 2024, on a per share basis to all shareholders of record as of June 21, 2024 (ex-dividend date June 21, 2024). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and abrdn Japan Equity Fund, Inc. (JEQ) which will pay on June 28, 2024, to al

      6/28/24 4:17:00 PM ET
      $ASGI
      $AWP
      $HQH
      $HQL
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies
    • abrdn U.S. Closed-End Funds Announce Results of Annual Meeting of Shareholders

      PHILADELPHIA, PA / ACCESSWIRE / June 26, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:HQH)(NYSE:THQ)(NYSE:THW) announced they each held their Annual Meeting of Shareholders (the "Meetings") on June 25, 2024. At the Meetings, shareholders of the respective Funds voted on the proposals set forth below:abrdn Healthcare Investors ("HQH")As of the record date, April 1, 2024, HQH had outstanding 50,624,847 shares of common stock. 80.52% of outstanding common stock were voted representing a quorum.Shareholders approved the election of two Class B Trustees to the Board: Number of Votes Cast ForPercentage of Votes Cast ForNumber of Votes Cast Against/WithheldPercentage of Votes Cast Against

      6/26/24 12:00:00 AM ET
      $ACP
      $HQH
      $THQ
      $THW
      Investment Managers
      Finance
      Finance Companies